GSE248769 1 V 0 SORAFENIB HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE248769 1 V 0 SORAFENIB HUMAN UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE248769 1 V 0 SORAFENIB HUMAN UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE248769 1 V 0 SORAFENIB HUMAN UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE248769 1 V 0 SORAFENIB HUMAN UP.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

A-kinase anchoring protein 17A

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

dehydrogenase/reductase X-linked

Gene

mitochondrial elongation factor 1 upstream open reading frame

Gene

collapsin response mediator protein 1

Gene

PDZ domain containing 4

Gene

solute carrier family 27 member 4

Gene

synaptotagmin 12

Gene

kelch domain containing 7A

  • Gene

    H4 clustered histone 15


  • Gene

    A-kinase anchoring protein 17A


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    mitochondrial elongation factor 1 upstream open reading frame


  • Gene

    collapsin response mediator protein 1


  • Gene

    PDZ domain containing 4


  • Gene

    solute carrier family 27 member 4


  • Gene

    synaptotagmin 12


  • Gene

    kelch domain containing 7A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.